Publication Name	World Journal of Hepatology
Manuscript ID	80998
Country	United States

Received	2022-10-21 00:12
Peer-Review Started	2022-10-21 00:16
To Make the First Decision
Return for Revision	2022-12-23 05:34
Revised	2023-01-06 03:05
Second Decision	2023-03-01 03:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-03-01 08:15
Articles in Press	2023-03-01 08:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-02 03:40
Publish the Manuscript Online	2023-03-22 11:20

ISSN	1948-5182 (online)
Open Access	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	To scan or not to scan: Use of transient elastography in an integrated health system
Manuscript Source	Unsolicited Manuscript
All Author List	Libby Stein, Rasham Mittal, Hubert Song, Joanie Chung and Amandeep Sahota
Funding Agency and Grant Number
Corresponding Author	Libby Stein, MD, Doctor, Internal Medicine, Kaiser Permanente Los Angeles Medical Center, 4867 Sunset Blvd, Los Angeles, CA 90027, United States. libby.x.stein@kp.org
Key Words	Non-alcoholic fatty liver disease; Transient elastography; FibroScan; Clinical decision support tool; Health care utilization; Primary care
Core Tip	This was a retrospective study of nearly 1000 patients with non-alcoholic fatty liver disease who underwent FibroScan. The purpose of this study was to compare patients before and after a clinical decision support tool was implemented. This tool was designed to guide primary care providers on the management of non-alcoholic fatty liver disease. After the tool was released, we saw higher rates of early-stage fibrosis diagnosed by FibroScan. We saw appropriate allocation of care, whereby patients with advanced fibrosis had more labs, imaging studies and specialty referrals. These results suggest non-alcoholic fatty liver disease can feasibly be diagnosed and managed in the primary care setting.
Publish Date	2023-03-22 11:20
Citation	Stein L, Mittal R, Song H, Chung J, Sahota A. To scan or not to scan: Use of transient elastography in an integrated health system. World J Hepatol 2023; 15(3): 419-430
URL	https://www.wjgnet.com/1948-5182/full/v15/i3/419.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i3.419

Full Article (PDF)	WJH-15-419-with-cover.pdf
Full Article (Word)	WJH-15-419.docx
Manuscript File	80998_Auto_Edited-JLW.docx
Answering Reviewers	80998-Answering reviewers.pdf
Audio Core Tip	80998-Audio core tip.mp3
Biostatistics Review Certificate	80998-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	80998-Conflict-of-interest statement.pdf
Copyright License Agreement	80998-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	80998-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	80998-Institutional review board statement.pdf
Supplementary Material	80998-Supplementary material.pdf
Peer-review Report	80998-Peer-review(s).pdf
Scientific Misconduct Check	80998-Bing-Liu GL-2.png
Scientific Editor Work List	80998-Scientific editor work list.pdf